A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL GROUP MULTICENTER TRIAL OF CVL-865 AS ADJUNCTIVE THERAPY IN ADULTS WITH DRUG-RESISTANT FOCAL ONSET SEIZURES (REALIZE TRIAL)
Brief description of study
The purpose of this study is to learn how well an investigational drug (referred to as “study drug”) called CVL-865 works as a possible treatment for epilepsy. An investigational drug is one that has not been approved by the United States Government (Food and Drug Administration or FDA). This research study will compare CVL-865 to a placebo. The placebo looks just like CVL-865, but contains no medicine. During this study, you may get the placebo instead of CVL-865. A placebo is used in research studies to compare the results and side effects of the drug being studied to the results and side effects of taking no medication. This allows us to see if the drug being studied works and what side effects it causes.
Interested participants should reach out to CECResearchStudyInfo@nyulangone.org.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
